Bio-Rad Laboratories Share Holder Equity 2010-2022 | BIO.B

Bio-Rad Laboratories share holder equity from 2010 to 2022. Share holder equity can be defined as the sum of preferred and common equity items
  • Bio-Rad Laboratories share holder equity for the quarter ending June 30, 2022 was $8.923B, a 23.05% decline year-over-year.
  • Bio-Rad Laboratories share holder equity for 2021 was $13.667B, a 38.33% increase from 2020.
  • Bio-Rad Laboratories share holder equity for 2020 was $9.88B, a 71.67% increase from 2019.
  • Bio-Rad Laboratories share holder equity for 2019 was $5.755B, a 43.15% increase from 2018.
Bio-Rad Laboratories Annual Share Holder Equity
(Millions of US $)
2021 $13,667
2020 $9,880
2019 $5,755
2018 $4,020
2017 $2,930
2016 $2,579
2015 $2,491
2014 $2,185
2013 $2,187
2012 $2,016
2011 $1,744
2010 $1,541
2009 $1,279
Bio-Rad Laboratories Quarterly Share Holder Equity
(Millions of US $)
2022-06-30 $8,923
2022-03-31 $10,183
2021-12-31 $13,667
2021-09-30 $15,332
2021-06-30 $11,595
2021-03-31 $10,609
2020-12-31 $9,880
2020-09-30 $8,825
2020-06-30 $7,353
2020-03-31 $6,293
2019-12-31 $5,755
2019-09-30 $5,131
2019-06-30 $5,487
2019-03-31 $4,864
2018-12-31 $4,020
2018-09-30 $4,900
2018-06-30 $4,639
2018-03-31 $4,488
2017-12-31 $2,930
2017-09-30 $2,848
2017-06-30 $2,811
2017-03-31 $2,707
2016-12-31 $2,579
2016-09-30 $2,703
2016-06-30 $2,615
2016-03-31 $2,544
2015-12-31 $2,491
2015-09-30 $2,430
2015-06-30 $2,359
2015-03-31 $2,199
2014-12-31 $2,185
2014-09-30 $2,177
2014-06-30 $2,250
2014-03-31 $2,233
2013-12-31 $2,187
2013-09-30 $2,124
2013-06-30 $2,071
2013-03-31 $2,031
2012-12-31 $2,016
2012-09-30 $1,935
2012-06-30 $1,852
2012-03-31 $1,840
2011-12-31 $1,744
2011-09-30 $1,694
2011-06-30 $1,726
2011-03-31 $1,613
2010-12-31 $1,541
2010-09-30 $1,428
2010-06-30 $1,303
2010-03-31 $1,301
2009-12-31 $1,279
2009-09-30 $1,228
2009-06-30 $1,128
2009-03-31 $1,058
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $13.545B $2.923B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $152.564B 9.26
GSK (GSK) United Kingdom $61.844B 7.43
QIAGEN (QGEN) Netherlands $9.898B 16.57
Ginkgo Bioworks Holdings (DNA) United States $5.908B 0.00
Myovant Sciences (MYOV) United Kingdom $2.391B 0.00
Arcus Biosciences (RCUS) United States $2.007B 39.18
Emergent Biosolutions (EBS) United States $1.039B 6.02
Biohaven Pharmaceutical Holding (BHVN) United States $0.878B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.392B 0.00
Zymeworks (ZYME) Canada $0.354B 0.00
Enzo Biochem (ENZ) United States $0.113B 0.00
Gelesis Holdings (GLS) United States $0.087B 0.00
SQZ Biotechnologies (SQZ) United States $0.075B 0.00
Ambrx Biopharma (AMAM) United States $0.045B 0.00